Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients. - Hooper, Perry B.; Farberg, Aaron S.; Fitzgerald, Alison L.; Siegel, Jennifer J.; Rackley, Briana B.; Prasai, Anesh; Kurley, Sarah J.; Goldberg, Matthew S.; Litchman, Graham H. (Cancer Investigation, 2022)